RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
CBD products that resemble tobacco products enter traditional retail outlets
Gammon, D. G., Gaber, J., & Lee, Y. O. (2021). CBD products that resemble tobacco products enter traditional retail outlets. Tobacco Control, 30(2), 237-238. Article 2019-055425. https://doi.org/10.1136/tobaccocontrol-2019-055452
The US Food and Drug Administration issued a final rule in 2016 deeming new tobacco products (any product made or derived from tobacco that is intended for human consumption, including any component, part or accessory of a tobacco product) under its authority. The products include electronic nicotine delivery systems, also referred to as vapes, vaporisers or electronic cigarettes, and products meeting the statutory definition that may be developed in the future. The US Agriculture Improvement Act of 2018 (known as the Farm Bill) removed hemp from the definition of marijuana in the Controlled Substance Act, effectively legalising cannabis-derived products with delta-9-tetrahydrocannabinol (THC) concentrations of no more than 0.3%. In contrast to high-THC cannabis products legally sold in some states, products primarily featuring cannabidiol (CBD) are now widely available in many forms nationally, including vaping liquids for use in vaping devices.
Despite the availability of CBD products consumed with vaping devices, there is little research …